Access
To read this story in full you will need to login or make a payment (see right).
Outlook
Nature 449, 166-169 (13 September 2007) | doi:10.1038/449166a; Published online 12 September 2007
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Senior Research Fellow - Atlantic Ocean Circulation and Climate
- University of Southampton
- Southampton / Hampshire United Kingdom
Senior Analyst - SCI
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
Neglected Diseases Mission possible
Andrew L. Hopkins1, Michael J. Witty2 & Solomon Nwaka3
Abstract
One billion people worldwide suffer from tropical diseases. Andrew L. Hopkins, Michael J. Witty and Solomon Nwaka explain how drug-discovery networks might be scaled up to address the lack of treatments cost-effectively.
New drugs are urgently needed for neglected tropical diseases and tuberculosis. Although one person in six suffers from such diseases, the few drugs available are not widely used, owing to problems with safety, administration, cost and — increasingly — resistance of the infectious agents1.
To read this story in full you will need to login or make a payment (see right).
